Alfred Adomako
Overview
Explore the profile of Alfred Adomako including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
122
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Samaraweera L, Adomako A, Rodriguez-Gabin A, McDaid H
Sci Rep
. 2017 May;
7(1):1900.
PMID: 28507307
Panobinostat (pano) is an FDA-approved histone deacetylase inhibitor. There is interest in evaluating alternate dosing schedules and novel combinations of pano for the treatment of upper aerodigestive and lung malignancies;...
2.
Adomako A, Calvo V, Biran N, Osman K, Chari A, Paton J, et al.
BMC Cancer
. 2015 May;
15:444.
PMID: 26025442
Background: The mechanisms allowing residual multiple myeloma (MM) cells to persist after bortezomib (Bz) treatment remain unclear. We hypothesized that studying the biology of bortezomib-surviving cells may reveal markers to...
3.
Smirnova T, Adomako A, Locker J, van Rooijen N, Prystowsky M, Segall J
Am J Pathol
. 2011 Jun;
178(6):2857-65.
PMID: 21641405
Invasion of tumor cells into the local stroma is an important component in cancer progression. Here we report studies of the in vivo invasion of head and neck squamous cell...
4.
Prystowsky M, Adomako A, Smith R, Kawachi N, McKimpson W, Atadja P, et al.
J Pathol
. 2009 Apr;
218(4):467-77.
PMID: 19402126
Head and neck squamous cell carcinoma represents a complex set of neoplasms arising in diverse anatomical locations. The site and stage of the cancer determine whether patients will be treated...